P. Beau et al., IS PARENTERAL NUTRITION-RELATED CHOLESTAT IC LIVER-DISEASE AN INFECTIOUS-DISEASE, Gastroenterologie clinique et biologique, 18(1), 1994, pp. 63-67
The aim of this retrospective study was fo determine whether total par
enteral nutrition-related liver disease was improved by intravenous an
tibiotics given for systemic sepsis. Liver function tests were perform
ed I month before, during and I month after one episode of sepsis trea
ted for 4 weeks (mean, range: 2-12), with systemic antibiotics, in 12
patients receiving parenteral nutrition for 13 months (mean, range: 1-
71) for short bowel syndrome in 10 of them. Cholestatic liver disease
appeared in all during nutrition (mean serum alkaline phosphatase acti
vity > 4 NJ. Liver test abnormalities observed at the beginning of ant
ibiotics treatment were not significantly different from those observe
d I month before sepsis. Antibiotic administration was followed by a s
ignificant decrease (P less than or equal to 0.03) in serum activities
of alkaline phosphatases, ALT and AST and bilirubinemia of 38, 41, 23
and 47 %, respectively. These results support the concept that parent
eral nutrition-associated cholestatic liver disease may be related to
intestinal bacterial overgrowth and suggest that if may be improved by
intravenous antibiotherapy.